Xylitol — Pharma Grade Anticaries Sweetener, Hyderabad

Surravi Phharma supplies Xylitol in IP, BP, EP, and USP grades in Hyderabad with ready stock. Xylitol is a five-carbon sugar alcohol widely used in chewable tablets, oral care products, and diabetic-safe pharmaceutical formulations. Call +91 8008002576 for bulk pricing, COA, and MSDS.

Xylitol has unique oral health properties: it inhibits the growth of Streptococcus mutans — the primary bacteria responsible for dental caries — by preventing its adhesion to tooth enamel and disrupting its fermentation pathway. Unlike sugars, Xylitol is not fermented by oral bacteria and does not produce acid. Regular Xylitol consumption (5–6 g/day through chewing gum, lozenges, or toothpaste) has been clinically shown to reduce cavity incidence by up to 85%. This makes it the preferred sweetener in dental-targeted pharmaceutical and nutraceutical products.

Xylitol has a significant negative heat of solution (−153.5 kJ/kg), producing a distinct cooling sensation when it dissolves on the tongue. This property is highly valued in chewable tablets, lozenges, and mouthwash formulations where a clean, cool mouthfeel is desirable — particularly in menthol-flavoured and oral care products. The cooling effect is comparable to that of Mannitol but more pronounced, and it complements mint flavours exceptionally well.

Yes. Xylitol has a glycaemic index (GI) of approximately 7 (compared to sucrose GI 65 and glucose GI 100) and provides approximately 2.4 kcal/g vs. sucrose's 4 kcal/g. Its absorption is slow and insulin-independent, making it safe for diabetic patients when used in typical pharmaceutical formulation quantities. It is commonly used in diabetic-safe sugar-free oral medications, vitamin chews, and probiotic supplements.

Like all polyol sugar alcohols, Xylitol can cause osmotic laxative effects (bloating, flatulence, diarrhoea) when consumed in excessive amounts. In adults, gastrointestinal tolerance varies but effects are typically seen above 40–50 g/day. In pharmaceutical formulations where per-dose Xylitol quantities are typically 0.5–3 g, GI effects are not a concern at recommended doses. This should be noted in labelling for high-dose nutraceutical products.